Connection
Nicholas Di bella to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Nicholas Di bella has written about Antimetabolites, Antineoplastic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.013 |
|
|
|
-
Venkatesh H, Di Bella N, Flynn TP, Vellek MJ, Boehm KA, Asmar L. Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma. Clin Lymphoma. 2004 Sep; 5(2):110-5.
Score: 0.013